Activities of Three Quinolones, Alone and in Combination with Extended-Spectrum Cephalosporins or Gentamicin, against Stenotrophomonas maltophilia
- 1 August 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (8) , 2002-2005
- https://doi.org/10.1128/aac.42.8.2002
Abstract
The present study examined the activities of trovafloxacin, levofloxacin, and ciprofloxacin, alone and in combination with cefoperazone, ceftazidime, cefpirome, and gentamicin, against 100 strains of Stenotrophomonas maltophilia by the MIC determination method and by synergy testing of the combinations by the time-kill and checkerboard titration methods for 20 strains. The respective MICs at which 50% and 90% of isolates were inhibited for the drugs used alone were as follows: trovafloxacin, 0.5 and 2.0 μg/ml; levofloxacin, 2.0 and 4.0 μg/ml; ciprofloxacin, 4.0 and 16.0 μg/ml; cefoperazone, >128.0 and >128.0 μg/ml; ceftazidime, 32.0 and >128.0 μg/ml; cefpirome, >128.0 and >128.0 μg/ml; and gentamicin, 128.0 and >128.0 μg/ml. Synergistic fractional inhibitory concentration indices (≤0.5) were found for ≥50% of strains for trovafloxacin-cefoperazone, trovafloxacin-ceftazidime, levofloxacin-cefoperazone, levofloxacin-ceftazidime, ciprofloxacin-cefoperazone, and ciprofloxacin-ceftazidime, with other combinations affecting fewer strains. For 20 strains tested by the checkerboard titration and time-kill methods, synergy (≥100-fold drop in count compared to the count achieved with the more active compound) was more pronounced after 12 h due to regrowth after 24 h. At 12 h, trovafloxacin at 0.004 to 0.5 μg/ml showed synergy with cefoperazone for 90% of strains, with ceftazidime for 95% of strains with cefpirome for 95% of strains, and with gentamicin for 65% of strains. Levofloxacin at 0.03 to 0.5 μg/ml and ciprofloxacin at 0.5 to 2.0 μg/ml showed synergy with cefoperazone for 80% of strains, with ceftazidime for 90 and 85% of strains, respectively, with cefpirome for 85 and 75% of strains, respectively, and with gentamicin for 65 and 75% of strains, respectively. Time-kill assays were more discriminatory than checkerboard titration assays in demonstrating synergy for all combinations.Keywords
This publication has 26 references indexed in Scilit:
- Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rodsAntimicrobial Agents and Chemotherapy, 1997
- Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studiesAntimicrobial Agents and Chemotherapy, 1997
- In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophiliaAntimicrobial Agents and Chemotherapy, 1995
- Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methodsAntimicrobial Agents and Chemotherapy, 1994
- Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitroAntimicrobial Agents and Chemotherapy, 1992
- In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1990
- Classification of beta-lactamases: groups 2c, 2d, 2e, 3, and 4Antimicrobial Agents and Chemotherapy, 1989
- Infections Caused by Pseudomonas maltophiliaArchives of internal medicine (1960), 1987
- Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873Antimicrobial Agents and Chemotherapy, 1984
- Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophiliaAntimicrobial Agents and Chemotherapy, 1982